Literature DB >> 15525272

NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia.

Fumimasa Amaya1, Goshun Shimosato, Masatoshi Nagano, Masashi Ueda, Satoru Hashimoto, Yoshifumi Tanaka, Hidenori Suzuki, Masaki Tanaka.   

Abstract

The transient receptor potential ion channel, TRPV1 plays an essential role in the development of inflammatory thermal hyperalgesia. We investigated the dependence of inflammatory TRPV1 induction on neurotrophic factor. Rat dorsal root ganglia (DRG) neurons were classified according to immunostaining for trk-A and IB4 and the effects of antibodies against NGF or GDNF on TRPV1 expression within the groups were then analysed by immunohistochemical means. The data were compared with the time course of trophic factor expression and the effects of their antibodies on thermal hyperalgesia against radiant heat after inflammation. Although the levels of both NGF and GDNF were increased by inflammation, NGF rapidly and transiently increased whereas GDNF increased gradually over a period of approximately one week. TRPV1 expression was increased within both trk-A positive and IB4 positive neurons after inflammation. Increased TRPV1 expression within trk-A positive neurons was prevented by anti-NGF but not by anti-GDNF, whereas TRPV1 induction within the IB4 positive group was blocked by anti-GDNF but not by anti-NGF. Both antibodies prevented the short latency of withdrawing an inflamed paw from radiant heat. These results suggest that inflammation differentially increases both NGF and GDNF, which facilitate TRPV1 expression within distinctive neurons to induce thermal hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525272     DOI: 10.1111/j.1460-9568.2004.03701.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  64 in total

Review 1.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 2.  Transient receptor potential channels in pain and inflammation: therapeutic opportunities.

Authors:  Mark A Schumacher
Journal:  Pain Pract       Date:  2010-03-02       Impact factor: 3.183

Review 3.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

Review 4.  Understanding inflammatory pain: ion channels contributing to acute and chronic nociception.

Authors:  John E Linley; Kirstin Rose; Lezanne Ooi; Nikita Gamper
Journal:  Pflugers Arch       Date:  2010-02-17       Impact factor: 3.657

Review 5.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

6.  TRPV1 expression level in isolectin B₄-positive neurons contributes to mouse strain difference in cutaneous thermal nociceptive sensitivity.

Authors:  Kentaro Ono; Yi Ye; Chi T Viet; Dongmin Dang; Brian L Schmidt
Journal:  J Neurophysiol       Date:  2015-03-18       Impact factor: 2.714

7.  Spinal nerve ligation in mouse upregulates TRPV1 heat function in injured IB4-positive nociceptors.

Authors:  Daniel Vilceanu; Prisca Honore; Quinn H Hogan; Cheryl L Stucky
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

8.  Glial cell line-derived neurotrophic factor family ligands enhance capsaicin-stimulated release of calcitonin gene-related peptide from sensory neurons.

Authors:  B S Schmutzler; S Roy; C M Hingtgen
Journal:  Neuroscience       Date:  2009-03-11       Impact factor: 3.590

9.  Contribution of nerve growth factor to augmented TRPV1 responses of muscle sensory neurons by femoral artery occlusion.

Authors:  Jihong Xing; Jian Lu; Jianhua Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.